The direct co-stimulation of tumor-specific effector CD4+ and CD8+ T cells (Teffs) has been demonstrated, particularly in combination with active vaccination [16], [17], [19]; yet, the in vivo effects of DTA-1 on Tregs have not been well-defined. This evidence concerns the gene CD4 and neoplasm.